• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer.长链非编码RNA MALAT1在卵巢癌中上调,并参与细胞增殖、迁移和凋亡过程。
Exp Ther Med. 2017 Jun;13(6):3055-3060. doi: 10.3892/etm.2017.4304. Epub 2017 Apr 5.
2
LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p.长链非编码RNA-MALAT1通过靶向miR-503-5p调控卵巢癌细胞的增殖和凋亡。
Onco Targets Ther. 2019 Aug 9;12:6297-6307. doi: 10.2147/OTT.S214689. eCollection 2019.
3
Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.长链非编码RNA转移相关肺腺癌转录本1通过miR-202调控Gli2的表达以促进胃癌进展。
Biomed Pharmacother. 2017 Jan;85:264-271. doi: 10.1016/j.biopha.2016.11.014. Epub 2016 Nov 22.
4
Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion.长链非编码 RNA MALAT1 在卵巢癌组织中上调,并促进 SK-OV-3 细胞增殖和侵袭。
Neoplasma. 2016;63(6):865-872. doi: 10.4149/neo_2016_605.
5
LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.长链非编码 RNA MALAT1 通过 PI3K-AKT 通路促进上皮性卵巢癌的增殖和转移。
Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3176-3184.
6
Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.敲低长链非编码 RNA 转移相关肺腺癌转录本 1 通过调节 microRNA-34a/细胞周期蛋白 D1 轴抑制膀胱癌细胞的增殖和迁移。
Int J Mol Med. 2019 Jan;43(1):547-556. doi: 10.3892/ijmm.2018.3959. Epub 2018 Oct 29.
7
Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line.长链非编码RNA MALAT1的抑制可抑制人卵巢癌SKOV3细胞系的致瘤性并诱导其凋亡。
Oncol Lett. 2016 Jun;11(6):3686-3692. doi: 10.3892/ol.2016.4435. Epub 2016 Apr 14.
8
MALAT1 affects ovarian cancer cell behavior and patient survival.MALAT1 影响卵巢癌细胞行为和患者生存。
Oncol Rep. 2018 Jun;39(6):2644-2652. doi: 10.3892/or.2018.6384. Epub 2018 Apr 19.
9
Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.长链非编码 RNA MALAT1 通过 Wnt/β-catenin 信号通路调节卵巢癌细胞增殖、迁移和凋亡。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3703-3712. doi: 10.26355/eurrev_201806_15249.
10
Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.缺氧诱导的非编码RNA分析揭示转移相关肺腺癌转录本1是血管平滑肌细胞增殖的重要调节因子。
Exp Biol Med (Maywood). 2017 Mar;242(5):487-496. doi: 10.1177/1535370216685434. Epub 2017 Jan 5.

引用本文的文献

1
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines.MALAT1在miR-34a基因敲除细胞系中的表达失调。
Noncoding RNA. 2025 Aug 5;11(4):60. doi: 10.3390/ncrna11040060.
2
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.上皮性卵巢癌中长链非编码RNA的最新进展——一项综述。
Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555.
3
Mechanisms of apoptosis-related non-coding RNAs in ovarian cancer: a narrative review.卵巢癌中凋亡相关非编码RNA的机制:一篇叙述性综述
Apoptosis. 2025 Apr;30(3-4):553-578. doi: 10.1007/s10495-024-02074-w. Epub 2025 Jan 20.
4
The long non-coding RNA MALAT1 regulates intestine host-microbe interactions and polyposis.长链非编码RNA MALAT1调节肠道宿主与微生物的相互作用及息肉病。
Front Cell Dev Biol. 2023 May 30;11:1168693. doi: 10.3389/fcell.2023.1168693. eCollection 2023.
5
Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine.重新审视卵巢癌的化疗耐药性:机制、生物标志物与精准医学。
Genes Dis. 2020 Dec 1;9(3):668-681. doi: 10.1016/j.gendis.2020.11.017. eCollection 2022 May.
6
Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview.解析长非编码 RNA 和 microRNAs 在卵巢癌发展中的协同调控网络:概述。
Cells. 2021 Jun 6;10(6):1407. doi: 10.3390/cells10061407.
7
Association of expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient.伊朗一名患者胃癌中的表达及其临床病理特征的意义
Gastroenterol Hepatol Bed Bench. 2021 Spring;14(2):108-114.
8
Long non-coding RNA MALAT1 plays a protective role in bronchopulmonary dysplasia via the inhibition of apoptosis and interaction with the Keap1/Nrf2 signal pathway.长链非编码RNA MALAT1通过抑制细胞凋亡以及与Keap1/Nrf2信号通路相互作用,在支气管肺发育不良中发挥保护作用。
Transl Pediatr. 2021 Feb;10(2):265-275. doi: 10.21037/tp-20-200.
9
LncRNA MALAT-1 promotes growth and metastasis of epithelial ovarian cancer via sponging microrna-22.长链非编码RNA MALAT-1通过吸附微小RNA-22促进上皮性卵巢癌的生长和转移。
Am J Transl Res. 2020 Nov 15;12(11):6977-6987. eCollection 2020.
10
Long non-coding RNA SNHG15 in various cancers: a meta and bioinformatic analysis.长链非编码 RNA SNHG15 在多种癌症中的作用:一项荟萃分析和生物信息学分析。
BMC Cancer. 2020 Nov 26;20(1):1156. doi: 10.1186/s12885-020-07649-9.

本文引用的文献

1
Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).卵巢、输卵管和腹膜癌的分期分类:国际妇产科联盟(FIGO)指南的节略再版
Obstet Gynecol. 2015 Jul;126(1):171-4. doi: 10.1097/AOG.0000000000000917.
2
Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer.长链非编码RNA Linc00152参与胃癌的细胞周期阻滞、细胞凋亡、上皮-间质转化、细胞迁移和侵袭。
Cell Cycle. 2015;14(19):3112-23. doi: 10.1080/15384101.2015.1078034. Epub 2015 Aug 3.
3
Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.长链非编码RNA linc00617在乳腺癌中表现出致癌活性。
Mol Carcinog. 2017 Jan;56(1):3-17. doi: 10.1002/mc.22338. Epub 2015 Jul 24.
4
MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA-DNA triplex structures.MEG3长链非编码RNA通过形成RNA-DNA三链体结构来调控转化生长因子-β(TGF-β)信号通路相关基因。
Nat Commun. 2015 Jul 24;6:7743. doi: 10.1038/ncomms8743.
5
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.长链非编码RNA MALAT1的下调通过PI3K-AKT途径诱导乳腺癌上皮-间质转化。
Int J Clin Exp Pathol. 2015 May 1;8(5):4881-91. eCollection 2015.
6
Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.长链非编码RNA HOTAIR是一种由缺氧诱导因子-1α激活的恶性肿瘤驱动因子,可增强非小细胞肺癌中缺氧癌细胞的增殖、迁移和侵袭能力。
Tumour Biol. 2015 Dec;36(12):9179-88. doi: 10.1007/s13277-015-3453-8. Epub 2015 Jun 19.
7
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.PRUNE2是一种由内含子长链非编码RNA PCA3调控的人类前列腺癌抑制因子。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8403-8. doi: 10.1073/pnas.1507882112. Epub 2015 Jun 15.
8
Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer.长链非编码RNA ANRIL预测浆液性卵巢癌预后不良并促进其侵袭/转移。
Int J Oncol. 2015;46(6):2497-505. doi: 10.3892/ijo.2015.2943. Epub 2015 Mar 31.
9
Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.长链非编码RNA MALAT1的上调促进食管鳞状细胞癌的增殖和转移。
J Exp Clin Cancer Res. 2015 Jan 22;34(1):7. doi: 10.1186/s13046-015-0123-z.
10
Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.长链非编码 RNA MALAT1 通过 Ezh2 促进肾透明细胞癌的侵袭转移并与 miR-205 相互作用。
Cancer Res. 2015 Apr 1;75(7):1322-31. doi: 10.1158/0008-5472.CAN-14-2931. Epub 2015 Jan 19.

长链非编码RNA MALAT1在卵巢癌中上调,并参与细胞增殖、迁移和凋亡过程。

Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer.

作者信息

Wu Liqin, Wang Xiaoyu, Guo Yuna

机构信息

Department of Obstetrics and Gynecology, Daqing Oilfield General Hospital, Daqing, Heilongjiang 163001, P.R. China.

State Key Laboratory of Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.

出版信息

Exp Ther Med. 2017 Jun;13(6):3055-3060. doi: 10.3892/etm.2017.4304. Epub 2017 Apr 5.

DOI:10.3892/etm.2017.4304
PMID:28587379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5450566/
Abstract

Ovarian cancer (OC) is the leading cause of mortality among gynecological malignancies. Although microRNAs are known to have a key regulatory role in OC, the involvement of long non-coding RNAs in the disease is less established. Previous studies have demonstrated that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a tumor oncogene in many cancers, though its role in OC remains unclear. The present study reported that MALAT1 expression was markedly upregulated in OC, by knockdown of MALAT1 expression , using RNA interference (RNAi) with small-interfering RNA (siRNA). It was found that MALAT1 expression was positively correlated with the International Federation of Gynecology and Obstetrics stages of OC, tumor histological grade and lymph node metastasis. In addition, the differential MALAT1 levels between a human ovarian epithelial cell line (HOSE) and OC cell lines (ES-2, OVCAR3, SKOV3 and HO8910) were compared . Notably, MALAT1 was expressed to a high level in OC cells. Furthermore, exogenous knockdown of MALAT1 significantly repressed growth and migration of OC cells, and promoted their apoptosis. Collectively, the current findings suggest that upregulation of MALAT1 in OC may facilitate tumorigenesis and metastasis. Knockdown of MALAT1 expression has potential as a novel target for the diagnosis and therapy of OC.

摘要

卵巢癌(OC)是妇科恶性肿瘤中导致死亡的主要原因。尽管已知微小RNA在OC中起关键调节作用,但长链非编码RNA在该疾病中的作用尚不明确。先前的研究表明,转移相关的肺腺癌转录本1(MALAT1)在许多癌症中是一种肿瘤癌基因,但其在OC中的作用仍不清楚。本研究报告称,通过使用小干扰RNA(siRNA)进行RNA干扰(RNAi)敲低MALAT1的表达,MALAT1在OC中的表达明显上调。研究发现,MALAT1的表达与OC的国际妇产科联盟分期、肿瘤组织学分级和淋巴结转移呈正相关。此外,还比较了人卵巢上皮细胞系(HOSE)和OC细胞系(ES-2、OVCAR3、SKOV3和HO8910)之间MALAT1水平的差异。值得注意的是,MALAT1在OC细胞中高表达。此外,外源性敲低MALAT1可显著抑制OC细胞的生长和迁移,并促进其凋亡。总的来说,目前的研究结果表明,OC中MALAT1的上调可能促进肿瘤发生和转移。敲低MALAT1的表达有潜力成为OC诊断和治疗的新靶点。